Significance of age and comorbidity as prognostic indicators for patients with bladder cancer

Asian Journal of Andrology

Volumn 12, Issue 5, 2010, Pages 766-774

  Ha, Moon Soo ^a   Chang, In Ho ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

age; comorbidity; neoplasm; prognostic indicator; urinary bladder

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; COMORBIDITY; CYSTECTOMY; DEMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OVERALL SURVIVAL;

AGE FACTORS; AGED; COMORBIDITY; CYSTECTOMY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 77956421501     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.29     Document Type: Article

References (23)

1. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superfcial bladder cancer. J Urol 2000; 163: 73-8.
2. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75.
3. Surveillance, Epidemiology, and end Results (SEER) Program SEER Stat Database: incidence. SEER 13 Registered Public Use, November 2004 Submission (1973-2000).
4. Ries LAG, Eisner MP, Kosary CL. SEER Cancer Statistics Review, 1973-1999. Bethesda: National Cancer Institute; 2002.
5. Steineck G, Hagman U, Gerhardsson M, Norell SE. Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-87. Int J Cancer 1990; 45: 1006-11.
6. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 1999; 91: 675-90.
7. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.
8. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel Jr EL. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291: 2441-7.
9. Epstein JI, Amin MB, Reuter VR, Mostof FK. The World Health Organization/International Society of Urological Pathology consensus classifcation of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-48.
10. Bergkvist A, Ljungqvist A, Moberger G. Classifcation of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371-8.
11. Prout Jr GR, Wesley MN, Yancik R, Ries LA, Havlik RJ, et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 2005; 104: 1638-47.
12. Derks W, de Leeuw RJ, Hordijk GJ. Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival. Curr Opin Otolaryngol 2005; 13: 92-6.
13. Benson Jr RC, Tomera KM, Kelalis PP. Transitional cell carcinoma of the bladder in children and adolescents. J Urol 1983; 130: 54-5.
14. Fitzpatrick JM, Reda M. Bladder carcinoma in patients 40 years old or less. J Urol 1986; 135: 53-4.
15. Linn JF, Sesterhenn I, Mostofi FK, Schoenberg M. The molecular characteristics of bladder cancer in young patients. J Urol 1998; 159: 1493-6.
16. Joudi FN, Smith BJ, O'Donnell MA, Konety BR. The impact of age on the response of patients with superfcial bladder cancer to intravesical immunotherapy. J Urol 2006; 175: 1634-9; discussion 9-40.
17. Heiner JG, Terris MK. Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guerin therapy. Urol Oncol 2008; 26: 137-40.
18. Wymenga AN, Slaets JP, Sleijfer DT. Treatment of cancer in old age, shortcomings and challenges. Neth J Med 2001; 59: 259-66.
19. Miller DC, Taub DA, Dunn RL, Montie JE, Wei JT. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 2003; 169: 105-9.
20. Farnham SB, Cookson MS, Alberts G, Smith Jr JA, Chang SS. Beneft of radical cystectomy in the elderly patient with signifcant co-morbidities. Urol Oncol 2004; 22: 178-81.
21. Hollenbeck BK, Miller DC, Taub D, Dunn RL, Underwood III W, et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004; 64: 292-7.
22. Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008; 112: 2384-92.
23. Megwalu II, Vlahiotis A, Radwan M, Piccirillo JF, Kibel AS. Prognostic impact of comorbidity in patients with bladder cancer. Eur Urol 2008; 53: 581-9.